<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="review-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47360/1995-4484-2023-672-677</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-3483</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS AND LECTURES</subject></subj-group></article-categories><title-group><article-title>Нетрудоспособность при системной склеродермии – что известно?</article-title><trans-title-group xml:lang="en"><trans-title>Work disability in systemic sclerosis – What is known?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7410-9784</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Клименко</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Klimenko</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>117997, Москва, ул. Островитянова, 1</p></bio><bio xml:lang="en"><p>Alesya A. Klimenko.</p><p>117997, Moscow, Ostrovitianova str., 1</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-4517-8435</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Михеева</surname><given-names>Е. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikheeva</surname><given-names>E. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Михеева Екатерина Павловна.</p><p>117997, Москва, ул. Островитянова, 1</p></bio><bio xml:lang="en"><p>Ekaterina P. Mikheeva.</p><p>117997, Moscow, Ostrovitianova str., 1</p></bio><email xlink:type="simple">katherina.mikheeva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4669-1006</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шостак</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Shostak</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>117997, Москва, ул. Островитянова, 1</p></bio><bio xml:lang="en"><p>Nadezhda A. Shostak.</p><p>117997, Moscow, Ostrovitianova str., 1</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6890-8777</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Демидова</surname><given-names>Н. A.</given-names></name><name name-style="western" xml:lang="en"><surname>Demidova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>117997, Москва, ул. Островитянова, 1</p></bio><bio xml:lang="en"><p>Natalia A. Demidova.</p><p>117997, Moscow, Ostrovitianova str., 1</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I. Pirogov Russian National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>01</day><month>01</month><year>2024</year></pub-date><volume>61</volume><issue>6</issue><fpage>672</fpage><lpage>677</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Клименко А.А., Михеева Е.П., Шостак Н.А., Демидова Н.A., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Клименко А.А., Михеева Е.П., Шостак Н.А., Демидова Н.A.</copyright-holder><copyright-holder xml:lang="en">Klimenko A.A., Mikheeva E.P., Shostak N.A., Demidova N.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/3483">https://rsp.mediar-press.net/rsp/article/view/3483</self-uri><abstract><p>Медико-социальная значимость системной склеродермии (ССД) высока. Прогрессирующее течение заболевания оказывает значимое влияние на функциональное состояние и профессиональную деятельность пациентов, приводя к ранней инвалидизации лиц трудоспособного возраста. В статье представлены данные по распространенности нетрудоспособности при ССД, в том числе в сравнении с другими ревматическими заболеваниями, а также по частоте потери и смены работы вследствие проблем, связанных с ССД. Обсуждается вклад заболевания в социально-экономическую сферу различных стран. Описаны составляющие влияния болезни на трудоспособность, основные подходы к количественной оценке показателей трудоспособности, наиболее часто используемые с этой целью инструменты. Обсуждаются данные разных авторов по результатам оценки трудоспособности у пациентов с ССД и выявленным предикторам ее потери.</p></abstract><trans-abstract xml:lang="en"><p>The medical and social significance of systemic sclerosis (SSc) is high. The progressive disease has a significant impact on the functional status, work participation and leads to early disability in patients of working age. The article presents data on the prevalence of work disability in patients with SSc in comparison with other rheumatic diseases, the frequency of separation from work and work transitions due to the problems connected with SSc, the socio-economic burden of SSc in different countries. The article specifies the components of the disease which affect the ability to work, the main approaches to quantify the indicators of working ability, describes the instruments most commonly used for this purpose. The data of various authors on working ability measurement and predictors of work disability in patients with SSc are presented.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>системная склеродермия</kwd><kwd>инвалидизация</kwd><kwd>нетрудоспособность</kwd><kwd>социально-экономическое бремя</kwd><kwd>абсентеизм</kwd><kwd>презентеизм</kwd><kwd>снижение производительности труда</kwd><kwd>снижение повседневной активности</kwd><kwd>предикторы потери трудоспособности</kwd><kwd>нарушение функционирования</kwd></kwd-group><kwd-group xml:lang="en"><kwd>systemic sclerosis</kwd><kwd>disablement</kwd><kwd>work disability</kwd><kwd>socio-economic burden</kwd><kwd>absenteeism</kwd><kwd>presenteeism</kwd><kwd>work productivity impairment</kwd><kwd>activity impairment</kwd><kwd>predictors of labour capacity loss</kwd><kwd>impaired functioning</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Singh MK, Clements PJ, Furst DE Maranian P, Khanna D. Work productivity in scleroderma: analysis from the University of California, Los Angeles scleroderma quality of life study. Arthritis Care Res (Hoboken). 2012;64(2):176-183. doi: 10.1002/acr.20676</mixed-citation><mixed-citation xml:lang="en">Singh MK, Clements PJ, Furst DE Maranian P, Khanna D. Work productivity in scleroderma: analysis from the University of California, Los Angeles scleroderma quality of life study. Arthritis Care Res (Hoboken). 2012;64(2):176-183. doi: 10.1002/acr.20676</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Hudson M, Steele R, Lu Y, Thombs BD; Canadian Scleroderma Research Group; Baron M. Work disability in systemic sclerosis. J Rheumatol. 2009;36(11):2481-2486. doi: 10.3899/jrheum.081237</mixed-citation><mixed-citation xml:lang="en">Hudson M, Steele R, Lu Y, Thombs BD; Canadian Scleroderma Research Group; Baron M. Work disability in systemic sclerosis. J Rheumatol. 2009;36(11):2481-2486. doi: 10.3899/jrheum.081237</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lee JJY, Gignac MAM, Johnson SR. Employment outcomes in systemic sclerosis. Best Pract Res Clin Rheumatol. 2021;35(3):101667. doi: 10.1016/j.berh.2021.101667</mixed-citation><mixed-citation xml:lang="en">Lee JJY, Gignac MAM, Johnson SR. Employment outcomes in systemic sclerosis. Best Pract Res Clin Rheumatol. 2021;35(3):101667. doi: 10.1016/j.berh.2021.101667</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Ouimet JM, Pope JE, Gutmanis I, Koval J. Work disability in scleroderma is greater than in rheumatoid arthritis and is predicted by high HAQ scores. Open Rheumatol J. 2008;2:44-52. doi: 10.2174/1874312900802010044</mixed-citation><mixed-citation xml:lang="en">Ouimet JM, Pope JE, Gutmanis I, Koval J. Work disability in scleroderma is greater than in rheumatoid arthritis and is predicted by high HAQ scores. Open Rheumatol J. 2008;2:44-52. doi: 10.2174/1874312900802010044</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Mau W, Listing J, Huscher D, Zeidler H, Zink A. Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol. 2005;32(4):721-728.</mixed-citation><mixed-citation xml:lang="en">Mau W, Listing J, Huscher D, Zeidler H, Zink A. Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol. 2005;32(4):721-728.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Morrisroe K, Sudararajan V, Stevens W, Sahhar J, Zochling J, Roddy J, et al. Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life. Rheumatology (Oxford). 2018;57(1):73-83. doi: 10.1093/rheumatology/kex362</mixed-citation><mixed-citation xml:lang="en">Morrisroe K, Sudararajan V, Stevens W, Sahhar J, Zochling J, Roddy J, et al. Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life. Rheumatology (Oxford). 2018;57(1):73-83. doi: 10.1093/rheumatology/kex362</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Клабукова ДЛ, Крысанова ВС, Ермолаева ТН, Давыдовская МВ, Кокушкин КА. Социально-экономическое бремя системной склеродермии: систематический обзор. Фармакоэкономика. Современная фармакоэкономика и фармакоэпидемиология. 2020;13(3):291-303. doi: 10.17749/2070-4909/farmakoekonomika.2020.041</mixed-citation><mixed-citation xml:lang="en">Klabukova DL, Krysanova VS, Ermolaeva TN, Davydovskaya MV, Kokushkin KA. Economic burden of systemic sclerosis: Systematic review. Farmakoekonomika. Modern Pharmacoeconomics and Pharmacoepidemiology. 2020;13(3):291-303 (In Russ.). doi: 10.17749/2070-4909/farmakoekonomika.2020.041</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Knarborg M, Løkke A, Hilberg O, Ibsen R, Sikjaer MG. Direct and indirect costs of systemic sclerosis and associated interstitial lung disease: A nationwide population-based cohort study. Respirology. 2022;27(5):341-349. doi: 10.1111/resp.14234</mixed-citation><mixed-citation xml:lang="en">Knarborg M, Løkke A, Hilberg O, Ibsen R, Sikjaer MG. Direct and indirect costs of systemic sclerosis and associated interstitial lung disease: A nationwide population-based cohort study. Respirology. 2022;27(5):341-349. doi: 10.1111/resp.14234</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Xiang L, Kua SMY, Low AHL. Work productivity and economic burden of systemic sclerosis in a multiethnic Asian population. Arthritis Care Res (Hoboken). 2022;74(5):818-827. doi: 10.1002/acr.24521</mixed-citation><mixed-citation xml:lang="en">Xiang L, Kua SMY, Low AHL. Work productivity and economic burden of systemic sclerosis in a multiethnic Asian population. Arthritis Care Res (Hoboken). 2022;74(5):818-827. doi: 10.1002/acr.24521</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Padala SD, Lao C, Solanki K, White D. Direct and indirect health-related costs of systemic sclerosis in New Zealand. Int J Rheum Dis. 2022;25(12):1386-1394. doi: 10.1111/1756-185X.14433</mixed-citation><mixed-citation xml:lang="en">Padala SD, Lao C, Solanki K, White D. Direct and indirect health-related costs of systemic sclerosis in New Zealand. Int J Rheum Dis. 2022;25(12):1386-1394. doi: 10.1111/1756-185X.14433</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sandqvist G, Scheja A, Hesselstrand R. Pain, fatigue and hand function closely correlated to work ability and employment status in systemic sclerosis. Rheumatology (Oxford). 2010;49(9):1739-1746. doi: 10.1093/rheumatology/keq145</mixed-citation><mixed-citation xml:lang="en">Sandqvist G, Scheja A, Hesselstrand R. Pain, fatigue and hand function closely correlated to work ability and employment status in systemic sclerosis. Rheumatology (Oxford). 2010;49(9):1739-1746. doi: 10.1093/rheumatology/keq145</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Peres N, Morell-Dubois S, Hachulla E, Hatron PY, Duhamel A, Godard D, et al. Sclérodermie systémique et difficultés professionnelles : résultats d’une enquête prospective [Systemic sclerosis and occupational difficulties: Results of a prospective study]. Rev Med Interne. 2017;38(11):718-724 (In French). doi: 10.1016/j.revmed.2017.06.006</mixed-citation><mixed-citation xml:lang="en">Peres N, Morell-Dubois S, Hachulla E, Hatron PY, Duhamel A, Godard D, et al. Sclérodermie systémique et difficultés professionnelles : résultats d’une enquête prospective [Systemic sclerosis and occupational difficulties: Results of a prospective study]. Rev Med Interne. 2017;38(11):718-724 (In French). doi: 10.1016/j.revmed.2017.06.006</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Nguyen C, Poiraudeau S, Mestre-Stanislas C, Rannou F, Bérezné A, Papelard A, et al. Employment status and socio-economic burden in systemic sclerosis: A cross-sectional survey. Rheumatology (Oxford). 2010;49(5):982-989. doi: 10.1093/rheumatology/kep400</mixed-citation><mixed-citation xml:lang="en">Nguyen C, Poiraudeau S, Mestre-Stanislas C, Rannou F, Bérezné A, Papelard A, et al. Employment status and socio-economic burden in systemic sclerosis: A cross-sectional survey. Rheumatology (Oxford). 2010;49(5):982-989. doi: 10.1093/rheumatology/kep400</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Decuman S, Smith V, Verhaeghe S, Deschepper E, Vermeiren F, De Keyser F. Work participation and work transition in patients with systemic sclerosis: A cross-sectional study. Rheumatology (Oxford). 2012;51(2):297-304. doi: 10.1093/rheumatology/ker288</mixed-citation><mixed-citation xml:lang="en">Decuman S, Smith V, Verhaeghe S, Deschepper E, Vermeiren F, De Keyser F. Work participation and work transition in patients with systemic sclerosis: A cross-sectional study. Rheumatology (Oxford). 2012;51(2):297-304. doi: 10.1093/rheumatology/ker288</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Кричевская ОА, Вакуленко ОЮ, Горячев ДВ, Эрдес ШФ. О некоторых подходах к количественной оценке снижения производительности труда при ревматических заболеваниях. Научно-практическая ревматология. 2012;54(5):90-97. doi: 10.14412/1995-4484-2012-1188</mixed-citation><mixed-citation xml:lang="en">Krichevskaya OA, Vakulenko OYu, Goryachev DV, Erdes SF. Some approaches to quantitative evaluation of reduced productivity in subjects with rheumatic diseases. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2012;50(5):90-97 (In Russ.). doi: 10.14412/1995-4484-2012-1188</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Cordeiro RA, Fischer FM, Shinjo SK. Systemic autoimmune diseases and work outcomes in Brazil: A scoping review. Rev Saude Publica. 2022;56:24. doi: 10.11606/s1518-8787.2022056003918</mixed-citation><mixed-citation xml:lang="en">Cordeiro RA, Fischer FM, Shinjo SK. Systemic autoimmune diseases and work outcomes in Brazil: A scoping review. Rev Saude Publica. 2022;56:24. doi: 10.11606/s1518-8787.2022056003918</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Вакуленко ОЮ, Кричевская ОА, Горячев ДВ, Эрдес ШФ. Взаимосвязь клинических характеристик ревматоидного артрита с трудоспособностью и производительностью труда. Научно-практическая ревматология. 2012;52(3):60-67. doi: 10.14412/1995-4484-2012-711</mixed-citation><mixed-citation xml:lang="en">Vakulenko OYu, Krichevskaya OA, Goryachev DV, Erdes SF. Relation-ship of the clinical characteristics of rheumatoid arthritis to work capacity and efficiency. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2012;52(3):60-67 (In Russ.). doi: 10.14412/1995-4484-2012-711</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Xavier RM, Zerbini CAF, Pollak DF, Morales-Torres JLA, Chalem P, Restrepo JFM, et al. Burden of rheumatoid arthritis on patients’ work productivity and quality of life. Adv Rheumatol. 2019;59(1):47. doi: 10.1186/s42358-019-0090-8</mixed-citation><mixed-citation xml:lang="en">Xavier RM, Zerbini CAF, Pollak DF, Morales-Torres JLA, Chalem P, Restrepo JFM, et al. Burden of rheumatoid arthritis on patients’ work productivity and quality of life. Adv Rheumatol. 2019;59(1):47. doi: 10.1186/s42358-019-0090-8</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Подряднова МВ, Балабанова РМ, Урумова ММ. Эрдес ШФ. Взаимосвязь клинических характеристик анкилозирующего спондилита с трудоспособностью и производительностью труда. Научно-практическая ревматология. 2014;52(5):513-519. doi: 10.14412/1995-4484-2014-513-519</mixed-citation><mixed-citation xml:lang="en">Podryadnova MV, Balabanova RM, Urumova MM, Erdes SF. Correlation between clinical characteristics of ankylosing spondylitis and work capacity and productivity. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2014;52(5):513-519 (In Russ.). doi: 10.14412/1995-4484-2014-513-519</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Sağ S, Nas K, Sağ MS, Tekeoğlu İ, Kamanlı A. Relationship of work disability between the disease activity, depression and quality of life in patients with ankylosing spondylitis. J Back Musculoskelet Rehabil. 2018;31(3):499-505. doi: 10.3233/BMR-169657</mixed-citation><mixed-citation xml:lang="en">Sağ S, Nas K, Sağ MS, Tekeoğlu İ, Kamanlı A. Relationship of work disability between the disease activity, depression and quality of life in patients with ankylosing spondylitis. J Back Musculoskelet Rehabil. 2018;31(3):499-505. doi: 10.3233/BMR-169657</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Boonen A, Boone C, Albert A, Mielants H. Understanding limitations in at-work productivity in patients with active ankylosing spondylitis: The role of work-related contextual factors. J Rheumatol. 2015;42(1):93-100. doi: 10.3899/jrheum.131287</mixed-citation><mixed-citation xml:lang="en">Boonen A, Boone C, Albert A, Mielants H. Understanding limitations in at-work productivity in patients with active ankylosing spondylitis: The role of work-related contextual factors. J Rheumatol. 2015;42(1):93-100. doi: 10.3899/jrheum.131287</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Scofield L, Reinlib L, Alarcón GS, Cooper GS. Employment and disability issues in systemic lupus erythematosus: A review. Arthritis Rheum. 2008;59(10):1475-1479. doi: 10.1002/art.24113</mixed-citation><mixed-citation xml:lang="en">Scofield L, Reinlib L, Alarcón GS, Cooper GS. Employment and disability issues in systemic lupus erythematosus: A review. Arthritis Rheum. 2008;59(10):1475-1479. doi: 10.1002/art.24113</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Baker K, Pope J. Employment and work disability in systemic lupus erythematosus: A systematic review. Rheumatology (Oxford). 2009;48(3):281-284. doi: 10.1093/rheumatology/ken477</mixed-citation><mixed-citation xml:lang="en">Baker K, Pope J. Employment and work disability in systemic lupus erythematosus: A systematic review. Rheumatology (Oxford). 2009;48(3):281-284. doi: 10.1093/rheumatology/ken477</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Jetha A, Johnson SR, Gignac MAM. Unmet workplace support needs and lost productivity of workers with systemic sclerosis: A path analysis study. Arthritis Care Res (Hoboken). 2021;73(3):423-431. doi: 10.1002/acr.24123</mixed-citation><mixed-citation xml:lang="en">Jetha A, Johnson SR, Gignac MAM. Unmet workplace support needs and lost productivity of workers with systemic sclerosis: A path analysis study. Arthritis Care Res (Hoboken). 2021;73(3):423-431. doi: 10.1002/acr.24123</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lerner D, Amick BC 3rd, Rogers WH, Malspeis S, Bungay K. The work limitations questionnaire. Med Care. 2001;39(1):72-85. doi: 10.1097/00005650-200101000-00009</mixed-citation><mixed-citation xml:lang="en">Lerner D, Amick BC 3rd, Rogers WH, Malspeis S, Bungay K. The work limitations questionnaire. Med Care. 2001;39(1):72-85. doi: 10.1097/00005650-200101000-00009</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Tang K, Beaton DE, Boonen A, Gignac MA, Bombardier C. Measures of work disability and productivity: Rheumatoid Arthritis Specific Work Productivity Survey (WPS-RA), Workplace Activity Limitations Scale (WALS), Work Instability Scale for Rheumatoid Arthritis (RA-WIS), Work Limitations Questionnaire (WLQ), and Work Productivity and Activity Impairment Questionnaire (WPAI). Arthritis Care Res (Hoboken). 2011;63(11):337-349. doi: 10.1002/acr.20633</mixed-citation><mixed-citation xml:lang="en">Tang K, Beaton DE, Boonen A, Gignac MA, Bombardier C. Measures of work disability and productivity: Rheumatoid Arthritis Specific Work Productivity Survey (WPS-RA), Workplace Activity Limitations Scale (WALS), Work Instability Scale for Rheumatoid Arthritis (RA-WIS), Work Limitations Questionnaire (WLQ), and Work Productivity and Activity Impairment Questionnaire (WPAI). Arthritis Care Res (Hoboken). 2011;63(11):337-349. doi: 10.1002/acr.20633</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Morrisroe K, Huq M, Stevens W, Rabusa C, Proudman SM, Nikpour M; and the Australian Scleroderma Interest Group (ASIG). Determinants of unemployment amongst Australian systemic sclerosis patients: Results from a multicentre cohort study. Clin Exp Rheumatol. 2016;34(Suppl 100(5)):79-84.</mixed-citation><mixed-citation xml:lang="en">Morrisroe K, Huq M, Stevens W, Rabusa C, Proudman SM, Nikpour M; and the Australian Scleroderma Interest Group (ASIG). Determinants of unemployment amongst Australian systemic sclerosis patients: Results from a multicentre cohort study. Clin Exp Rheumatol. 2016;34(Suppl 100(5)):79-84.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Bérezné A, Seror R, Morell-Dubois S, de Menthon M, Fois E, Dzeing-Ella A, et al. Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res (Hoboken). 2011;63(2):277-285. doi: 10.1002/acr.20342</mixed-citation><mixed-citation xml:lang="en">Bérezné A, Seror R, Morell-Dubois S, de Menthon M, Fois E, Dzeing-Ella A, et al. Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res (Hoboken). 2011;63(2):277-285. doi: 10.1002/acr.20342</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Steen VD, Medsger TA. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum. 1997;40:1984-1991. doi: 10.1002/art.1780401110</mixed-citation><mixed-citation xml:lang="en">Steen VD, Medsger TA. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum. 1997;40:1984-1991. doi: 10.1002/art.1780401110</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Schnitzer M, Hudson M, Baron M, Steele R; Canadian Scleroderma Research Group. Disability in systemic sclerosis – A longitudinal observational study. J Rheumatol. 2011;38(4):685-692. doi: 10.3899/jrheum.100635</mixed-citation><mixed-citation xml:lang="en">Schnitzer M, Hudson M, Baron M, Steele R; Canadian Scleroderma Research Group. Disability in systemic sclerosis – A longitudinal observational study. J Rheumatol. 2011;38(4):685-692. doi: 10.3899/jrheum.100635</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Jaeger VK, Distler O, Maurer B, Czirják L, Lóránd V. Functional disability and its predictors in systemic sclerosis: A study from the DeSScipher project within the EUSTAR group. Rheumatology (Oxford). 2018;57(3):441-450. doi: 10.1093/rheumatology/kex182</mixed-citation><mixed-citation xml:lang="en">Jaeger VK, Distler O, Maurer B, Czirják L, Lóránd V. Functional disability and its predictors in systemic sclerosis: A study from the DeSScipher project within the EUSTAR group. Rheumatology (Oxford). 2018;57(3):441-450. doi: 10.1093/rheumatology/kex182</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Valenzuela A, Baron M, Rodriguez-Reyna TS, Proudman S, Khanna D. Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis. Semin Arthritis Rheum. 2020;50(5):891-896. doi: 10.1016/j.semarthrit.2020.06.007</mixed-citation><mixed-citation xml:lang="en">Valenzuela A, Baron M, Rodriguez-Reyna TS, Proudman S, Khanna D. Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis. Semin Arthritis Rheum. 2020;50(5):891-896. doi: 10.1016/j.semarthrit.2020.06.007</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Guillevin L, Hunsche E, Denton CP, Krieg T, Schwierin B, Rosenberg D, et al.; DUO Registry Group. Functional impairment of systemic scleroderma patients with digital ulcerations: Results from the DUO Registry. Clin Exp Rheumatol. 2013;31(2 Suppl 76):71-80.</mixed-citation><mixed-citation xml:lang="en">Guillevin L, Hunsche E, Denton CP, Krieg T, Schwierin B, Rosenberg D, et al.; DUO Registry Group. Functional impairment of systemic scleroderma patients with digital ulcerations: Results from the DUO Registry. Clin Exp Rheumatol. 2013;31(2 Suppl 76):71-80.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Castellví I, Eguiluz S, Escudero-Contreras A, Ríos JJ, Calvo-Alén J, Callejas-Rubio JL, et al.; LAUDES Study Group. LAUDES Study: Impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients. Rheumatol Int. 2019;39(11):1875-1882. doi: 10.1007/s00296-019-04436-z</mixed-citation><mixed-citation xml:lang="en">Castellví I, Eguiluz S, Escudero-Contreras A, Ríos JJ, Calvo-Alén J, Callejas-Rubio JL, et al.; LAUDES Study Group. LAUDES Study: Impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients. Rheumatol Int. 2019;39(11):1875-1882. doi: 10.1007/s00296-019-04436-z</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Sharif R, Mayes MD, Nicassio PM, Gonzalez EB, Draeger H, McNearney TA, et al.; GENISOS Study Group. Determinants of work disability in patients with systemic sclerosis: A longitudinal study of the GENISOS cohort. Semin Arthritis Rheum. 2011;41(1):38-47. doi: 10.1016/j.semarthrit.2011.01.002</mixed-citation><mixed-citation xml:lang="en">Sharif R, Mayes MD, Nicassio PM, Gonzalez EB, Draeger H, McNearney TA, et al.; GENISOS Study Group. Determinants of work disability in patients with systemic sclerosis: A longitudinal study of the GENISOS cohort. Semin Arthritis Rheum. 2011;41(1):38-47. doi: 10.1016/j.semarthrit.2011.01.002</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Poole JL, Anwar S, Mendelson C, Allaire S. Workplace barriers encountered by employed persons with systemic sclerosis. Work. 2016;55(4):923-929. doi: 10.3233/WOR-162448</mixed-citation><mixed-citation xml:lang="en">Poole JL, Anwar S, Mendelson C, Allaire S. Workplace barriers encountered by employed persons with systemic sclerosis. Work. 2016;55(4):923-929. doi: 10.3233/WOR-162448</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
